The Current Ratio as of November 2024 (TTM) for Atai Life Sciences N.V. (ATAI) is 6.68

According to Atai Life Sciences N.V.’s latest financial reports and current stock price. The company's current Current Ratio is 6.68. This represents a change of -23.12% compared to the average of 8.69 of the last 4 quarters.

Atai Life Sciences N.V. (ATAI) Historical Current Ratio (quarterly & annually)

How has ATAI Current Ratio performed in the past?

The mean historical Current Ratio of Atai Life Sciences N.V. over the last ten years is 14.81. The current 6.68 Current Ratio has changed 4.41% with respect to the historical average. Over the past ten years (40 quarters), ATAI's Current Ratio was at its highest in in the June 2021 quarter at 32.26. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Atai Life Sciences N.V. (ATAI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Atai Life Sciences N.V. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Atai Life Sciences N.V. (ATAI) Average Current Ratio

How has ATAI Current Ratio performed in the past?

The current Current Ratio of Atai Life Sciences N.V. (ATAI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Atai Life Sciences N.V. (ATAI) Current Ratio vs. Peers

How is ATAI’s Current Ratio compared to its peers?

Atai Life Sciences N.V.’s Current Ratio is greater than Mind Medicine (MindMed) Inc. (5.92), greater than Seelos Therapeutics, Inc. (0.08), less than GH Research PLC (19.60), greater than Freeline Therapeutics Holdings plc (1.95), less than Cybin Inc. (41.70), greater than Fortress Biotech, Inc. (1.37), greater than Bio-Path Holdings, Inc. (1.67), greater than Vaccinex, Inc. (0.42), less than Eliem Therapeutics, Inc. (60.41), greater than Opthea Limited (2.94), less than Molecular Partners AG (14.58), less than Edgewise Therapeutics, Inc. (30.24), less than iTeos Therapeutics, Inc. (18.08), greater than Wesana Health Holdings Inc. (0.13), greater than BioVaxys Technology Corp. (0.39), greater than Algernon Pharmaceuticals Inc. (0.36), greater than AXIM Biotechnologies, Inc. (0.00),

Build a custom stock screener for Atai Life Sciences N.V. (ATAI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atai Life Sciences N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atai Life Sciences N.V. (ATAI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atai Life Sciences N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.